JAK-STAT Inhibitor - 搜索视频

为你精选

Dr Scandura on the SENTRY-2 Trial of Single-Agent Selinexor in JAK Inhibitor–Naive Myelofibrosis

Dr Scandura on the SENTRY-2 Trial of Single-Agent Selinexor in JAK Inhibitor–Naive Myelofibrosis

Joseph M. Scandura, MD, PhD, discusses the phase 2 SENTRY-2 study evaluating single-agent selinexor in JAK inhibitor–naive myelofibrosis.

onclive.com1 个月前

Janus kinase inhibitor Uses

Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Patients with Myelofibrosis: Results of the MANIFEST-2 Randomized, Double-Blind, Phase 3 Study

Pelabresib in Combination with Ruxolitinib for Janus

11 个月之前

BRIGHTSTAR: Local Consolidative Therapy with Brigatinib in Tyrosine Kinase Inhibitor-Naïve ALK-Rearranged Metastatic NSCLC

BRIGHTSTAR: Local Consolidative Therapy with Brigatinib in

2023年10月6日

Dr Raj Chovatiya Explains Oral JAK Inhibitor Monitoring Protocols for AD Treatment

Dr Raj Chovatiya Explains Oral JAK Inhibitor Monitoring

热门视频

Dr Amanam on Criteria for Selecting a JAK Inhibitor in Myelofibrosis

Dr Amanam on Criteria for Selecting a JAK Inhibitor in

PharmaC - SAR of HMG CoA reductase inhibitor /SAR of...

PharmaC - SAR of HMG CoA reductase inhibitor /SAR of...

FacebookPharmaC

已浏览 203 次2020年8月15日

Verunsicherung bei Rheumamedikament

Verunsicherung bei Rheumamedikament

Janus kinase inhibitor Side Effects

Management of mTOR Inhibitor Side Effects in Breast Cancer

Management of mTOR Inhibitor Side Effects in Breast Cancer

2013年6月9日

Johnson & Johnson COVID-19 vaccine: What are the side effects?

Johnson & Johnson COVID-19 vaccine: What are the side

FacebookMedical News Today

已浏览 7321 次2021年4月27日

COVID-19 FAQ 165: Oral JAK Inhibitor Now an Option

COVID-19 FAQ 165: Oral JAK Inhibitor Now an Option

FacebookDr K K Aggarwal

已浏览 4508 次2020年11月23日